Related Experiment Videos
Gene expression profiles post Roux-en-Y gastric bypass
Yuan Xu1, Eduardo J b Ramos, Frank Middleton
1Surgical Metabolism and Nutrition Laboratory, Neuroscience Program, Department of Surgery, SUNY Upstate Medical University, Syracuse, NY 13210, USA.
Surgery
|August 10, 2004
Summary
Roux-en-Y gastric bypass (RYGB) significantly reduces body weight and food intake by altering gene expression in the hypothalamus and fat tissue. These molecular changes in metabolic pathways contribute to weight loss after RYGB surgery.
Area of Science:
- Endocrinology
- Molecular Biology
- Bariatric Surgery
Background:
- The hypothalamus regulates food intake and fat deposition.
- Roux-en-Y gastric bypass (RYGB) is an effective weight-loss surgery.
- Understanding the molecular mechanisms of RYGB-induced weight loss is crucial.
Purpose of the Study:
- To investigate the molecular mechanisms of weight loss following RYGB.
- To correlate changes in gene expression profiles in the hypothalamus and subcutaneous abdominal fat.
- To identify key genes and pathways involved in RYGB-induced metabolic changes.
Main Methods:
- Diet-induced obese rats underwent RYGB, sham operation (SO-Obese), or pair-feeding (PF).
- Gene expression profiles in the hypothalamic arcuate nucleus (ARC) and subcutaneous abdominal fat (SAF) were analyzed.
- Body weight, food intake, and plasma biochemical indices were measured.
Main Results:
- RYGB led to significant decreases in body weight, food intake, and SAF compared to SO-Obese rats.
- Shared gene expression profiles between ARC and SAF after RYGB were primarily related to metabolic pathways (carbohydrate, fat, neuropeptide, cytokines).
- These expression profiles mirrored those in control groups, suggesting a coordinated molecular response.
Conclusions:
- RYGB-induced weight loss is associated with significant alterations in gene expression profiles.
- These gene expression changes in metabolic pathways likely contribute to the observed weight loss.
- The study provides insights into the molecular underpinnings of RYGB's effectiveness.